Skip to main content
Top
Published in: Rheumatology International 3/2011

01-03-2011 | Case Report

Uveitis in celiac disease with an excellent response to gluten-free diet: third case described

Authors: Karin Klack, Rosa Maria Rodrigues Pereira, Jozélio Freire de Carvalho

Published in: Rheumatology International | Issue 3/2011

Login to get access

Abstract

To describe the case of a patient with celiac disease who achieved a complete response to a gluten-free diet. A 28-year-old woman presented with diarrhea, oral ulcers, and refractory uveitis of 2.5-years duration. She was treated with prednisone, mydriatic drops, and infliximab with no response. She was referred to our hospital at which point her previous diagnosis of uveitis was confirmed; she was also diagnosed with right-sided sacro-iliitis. The patient did not have arthritis or any skin conditions. Three tests for fecal parasites and a fecal leukocyte were negative. Endoscopy revealed atrophic appearance of the duodenal mucosa. Biopsy showed atrophy of the duodenal villi with intra-epithelial lymphocytes, hyperplasia of the crypts, and chronic inflammatory infiltrate. The search for antiendomysial antibody was >1/1,280. The patient was started on a gluten-free diet and after 3 months demonstrated significant improvement of gastrointestinal symptoms and uveitis, as well as a reduction of antiendomysial antibodies (1/80). After 6 months, there was complete remission of gastrointestinal symptoms and total control of uveitis. The antiendomysial antibody was negative at that time. Clinical uveitis as a manifestation of celiac disease has been described in only two cases in the literature. This case study is the third to demonstrate that uveitis is a clinical symptom that can be addressed in patients with celiac disease.
Literature
1.
go back to reference Cianci R, Cammarota G, Lolli S, Gasbarrini GB, Pandolfi F (2008) Abnormal synthesis of IgA in coeliac disease and related disorders. J Biol Regul Homeost Agents 22(2):99–104PubMed Cianci R, Cammarota G, Lolli S, Gasbarrini GB, Pandolfi F (2008) Abnormal synthesis of IgA in coeliac disease and related disorders. J Biol Regul Homeost Agents 22(2):99–104PubMed
2.
go back to reference Cassol CA, Pellegrin CP, Wahys MLC, Pires MMS, Nassar SM (2007) Clinical profile of Santa Catarina members of Brazilian Celiac Association. Arq Gastroenterol 44:257–265CrossRefPubMed Cassol CA, Pellegrin CP, Wahys MLC, Pires MMS, Nassar SM (2007) Clinical profile of Santa Catarina members of Brazilian Celiac Association. Arq Gastroenterol 44:257–265CrossRefPubMed
3.
go back to reference Upton MP (2008) Give us this daily bread—envolving concepts in celiac sprue. Arch Pathol Lab Med 132:1594–1599PubMed Upton MP (2008) Give us this daily bread—envolving concepts in celiac sprue. Arch Pathol Lab Med 132:1594–1599PubMed
4.
go back to reference Leeds JS, Hopper AD, Sanders DS (2008) Coelic disease. BMJ 88:157–170 Leeds JS, Hopper AD, Sanders DS (2008) Coelic disease. BMJ 88:157–170
6.
go back to reference Pereira CC, Correa PHS, Halpern A (2006) Case report: recently diagnosed celiac disease as aggravating factor of osteoporosis in an old woman. Arq Bras Endocrinol Metab 6:1127–1132 Pereira CC, Correa PHS, Halpern A (2006) Case report: recently diagnosed celiac disease as aggravating factor of osteoporosis in an old woman. Arq Bras Endocrinol Metab 6:1127–1132
7.
go back to reference Carroccio A, Ambrosiano G, Prima L et al (2008) Clinical symptoms in celiac patients on a gluten-free diet. Scand J Gastroenterol 43:1–7CrossRef Carroccio A, Ambrosiano G, Prima L et al (2008) Clinical symptoms in celiac patients on a gluten-free diet. Scand J Gastroenterol 43:1–7CrossRef
8.
go back to reference Karakan T, Ozyemisci-Taskiran O, Gunendi Z, Atalay F, Tuncer C (2007) Prevalence of IgA-antiendomysial antibody in a patient cohort with idiopathic low bone mineral density. World J Gastroenterol 13:2978–2982PubMed Karakan T, Ozyemisci-Taskiran O, Gunendi Z, Atalay F, Tuncer C (2007) Prevalence of IgA-antiendomysial antibody in a patient cohort with idiopathic low bone mineral density. World J Gastroenterol 13:2978–2982PubMed
9.
go back to reference Di Maita M, Amantia L, Morana G (1987) Association of uveitis, alopecia and celiac disease. Ophtalmologie 1:401PubMed Di Maita M, Amantia L, Morana G (1987) Association of uveitis, alopecia and celiac disease. Ophtalmologie 1:401PubMed
10.
go back to reference Hyrailles V, Desprez D, Beauerère L, de Ferrier F, Larrey D, Ramos J et al (1995) Uveitis complicating celiac disease and cured by gluten-free diet. Gastroenterol Clin Biol 19(5):543–544PubMed Hyrailles V, Desprez D, Beauerère L, de Ferrier F, Larrey D, Ramos J et al (1995) Uveitis complicating celiac disease and cured by gluten-free diet. Gastroenterol Clin Biol 19(5):543–544PubMed
11.
go back to reference Weiss K, Steinbrugger I, Weger M, Ardjomand N, Maier R, Wegscheider BJ et al (2009) Intravitreal VEGF levels in uveitis patients and treatment of uveitic macular oedema with intravitreal bevacizumab. Eye 23(9):1812–1818CrossRefPubMed Weiss K, Steinbrugger I, Weger M, Ardjomand N, Maier R, Wegscheider BJ et al (2009) Intravitreal VEGF levels in uveitis patients and treatment of uveitic macular oedema with intravitreal bevacizumab. Eye 23(9):1812–1818CrossRefPubMed
Metadata
Title
Uveitis in celiac disease with an excellent response to gluten-free diet: third case described
Authors
Karin Klack
Rosa Maria Rodrigues Pereira
Jozélio Freire de Carvalho
Publication date
01-03-2011
Publisher
Springer-Verlag
Published in
Rheumatology International / Issue 3/2011
Print ISSN: 0172-8172
Electronic ISSN: 1437-160X
DOI
https://doi.org/10.1007/s00296-009-1177-z

Other articles of this Issue 3/2011

Rheumatology International 3/2011 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.